CLCA3_Clac3 Activators
CLCA3 (Calcium-activated chloride channel regulator 3) Clac3 Activators belong to a distinctive chemical class that modulates the activity of the CLCA3 protein, a member of the calcium-activated chloride channel regulator family. CLCA3 plays a crucial role in ion channel regulation and chloride transport across cell membranes, particularly in epithelial tissues. This chemical class, known for its unique ability to activate CLCA3, influences cellular processes related to ion homeostasis and chloride conductance. The intricate interplay between CLCA3 and its activators underscores the importance of finely tuned cellular signaling mechanisms, highlighting the regulatory role of these compounds in controlling chloride channel function.
Structurally, CLCA3 Clac3 Activators are characterized by specific molecular motifs that interact with CLCA3, leading to conformational changes and subsequent activation of the chloride channel. The activation process is intricately linked to intracellular calcium levels, as CLCA3 responds to changes in calcium concentrations, thereby modulating chloride conductance in a calcium-dependent manner. Understanding the molecular details of the interaction between CLCA3 and its activators provides valuable insights into the physiological processes governed by these compounds. Further research is needed to elucidate the full spectrum of cellular functions influenced by CLCA3 Clac3 Activators, as their role extends beyond the regulation of ion channels, potentially contributing to broader cellular and
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, enhances CLCA3_Clac3 by binding to retinoic acid receptors (RARs) and modulating the retinoic acid signaling pathway. Activation of RARs influences the transcription of target genes, including CLCA3_Clac3, thereby enhancing its functional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in intracellular cAMP levels. Elevated cAMP levels, in turn, activate protein kinase A (PKA), which can phosphorylate and enhance the functional activity of CLCA3_Clac3. The forskolin-mediated cAMP-PKA pathway provides a direct route for the enhanced activation of CLCA3_Clac3 in response to forskolin treatment. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective protein kinase C (PKC) inhibitor. By inhibiting PKC, it can indirectly enhance CLCA3_Clac3 activity. PKC is involved in various signaling pathways, and its inhibition can lead to the removal of inhibitory signals, allowing for the heightened activation of CLCA3_Clac3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. Elevated calcium levels can activate calmodulin-dependent signaling pathways, indirectly enhancing CLCA3_Clac3 activity. Calmodulin interacts with various proteins, and its activation can influence downstream effectors that lead to the functional activation of CLCA3_Clac3. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable analog of cAMP. It directly activates the cAMP-dependent protein kinase (PKA), which can phosphorylate and enhance the functional activity of CLCA3_Clac3. The increased cAMP levels mimic the cellular response to forskolin, providing an alternative means to activate the cAMP-PKA pathway and subsequently enhance CLCA3_Clac3. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. By inhibiting HDACs, it promotes histone acetylation and alters chromatin structure, leading to increased accessibility of CLCA3_Clac3 gene for transcription. The epigenetic modulation induced by trichostatin A results in enhanced CLCA3_Clac3 expression and functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC by PMA can directly enhance the functional activity of CLCA3_Clac3, as PKC-mediated signaling pathways are intricately involved in regulating cellular processes that influence CLCA3_Clac3 function. The direct activation of PKC by PMA provides a specific mechanism for the enhanced activation of CLCA3_Clac3. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 is a calcium channel activator that enhances calcium influx. Increased intracellular calcium levels, facilitated by Bay K 8644, can activate signaling cascades involving calmodulin and other calcium-dependent proteins. These cascades indirectly lead to the enhanced functional activity of CLCA3_Clac3, as calcium-dependent pathways play a crucial role in modulating various cellular functions, including the activation of CLCA3_Clac3. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a major component of green tea, can activate the 5' adenosine monophosphate-activated protein kinase (AMPK) pathway. AMPK activation can modulate cellular energy status and influence downstream pathways, indirectly enhancing CLCA3_Clac3 activity. The specific activation of AMPK by EGCG provides a unique mechanism for the enhanced activation of CLCA3_Clac3 through metabolic regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a specific inhibitor of p38 mitogen-activated protein kinase (MAPK). Inhibition of p38 MAPK by SB 203580 can impact downstream signaling events that influence CLCA3_Clac3 activity. As p38 MAPK is part of a signaling network involved in stress response and inflammation, its inhibition by SB 203580 can indirectly enhance the functional activity of CLCA3_Clac3 by modulating the cellular environment in which CLCA3_Clac3 operates. | ||||||